CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.040
0.00 (0.00%)
At close: Nov 13, 2026, 4:00 PM EST
2.040
0.00 (0.00%)
Pre-market: Nov 16, 2026, 4:03 AM EST

CytomX Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
33.9612.6738.0517.17193.65205.53
Short-Term Investments
314.02124.3962.57157.34-99.7
Cash & Short-Term Investments
347.98137.05100.62174.51193.65305.23
Cash Growth
142.28%36.20%-42.34%-9.88%-36.55%-3.45%
Receivables
2.52.013.13.4335.990.79
Prepaid Expenses
4.654.863.5857.474.29
Total Current Assets
356.05143.92107.31182.94237.1310.3
Property, Plant & Equipment
6.194.710.616.1821.0225.32
Goodwill
0.950.950.950.950.950.95
Other Intangible Assets
0.330.440.580.730.881.02
Other Long-Term Assets
1.161.561.0910.941.82
Total Assets
364.68151.57120.53201.79260.89339.41

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.141.31.091.462.812.82
Accrued Expenses
16.4514.1712.3417.622.8230.62
Current Portion of Leases
0.534.245.154.594.083.62
Current Unearned Revenue
27.4226.8867.2132.27121.2740.82
Other Current Liabilities
-0.02--1.63-
Total Current Liabilities
45.5346.6285.77155.91152.6177.87
Long-Term Leases
3.86-4.249.3913.9818.06
Long-Term Unearned Revenue
25.861.5926.8680.05180.06243.94
Other Long-Term Liabilities
4.534.354.123.89--
Total Liabilities
79.7952.56120.99249.24346.64339.87

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
1,056810.84691.1675.91637.12623.34
Retained Earnings
-770.86-711.95-691.58-723.45-722.88-623.56
Comprehensive Income & Other
-0.320.110.030.10.01-0.24
Shareholders' Equity
284.8999.01-0.46-47.45-85.75-0.46
Total Liabilities & Equity
364.68151.57120.53201.79260.89339.41

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
4.394.249.3913.9718.0621.67
Net Cash (Debt)
343.59132.8191.24160.54175.59283.55
Net Cash Growth
148.93%45.57%-43.17%-8.58%-38.07%-2.64%
Net Cash Per Share
1.750.961.082.182.674.42
Filing Date Shares Outstanding
218170.1980.167.7266.2365.39
Total Common Shares Outstanding
217.95170.1980.167.3166.2365.39
Working Capital
310.5297.3121.5327.0284.49232.43
Book Value Per Share
1.310.58-0.01-0.70-1.29-0.01
Tangible Book Value
283.6197.62-1.99-49.13-87.58-2.43
Tangible Book Value Per Share
1.300.57-0.02-0.73-1.32-0.04
Machinery
-16.6216.6916.31717.75
Construction In Progress
---0.370.710.31
Leasehold Improvements
-1.62.011.981.741.74
SEC Filings: 10-K · 10-Q